FR2936710B1 - Composition veterinaire antiprolactinique destinee aux ruminants - Google Patents

Composition veterinaire antiprolactinique destinee aux ruminants

Info

Publication number
FR2936710B1
FR2936710B1 FR0805544A FR0805544A FR2936710B1 FR 2936710 B1 FR2936710 B1 FR 2936710B1 FR 0805544 A FR0805544 A FR 0805544A FR 0805544 A FR0805544 A FR 0805544A FR 2936710 B1 FR2936710 B1 FR 2936710B1
Authority
FR
France
Prior art keywords
ruminants
veterinary composition
antiprolactinic
antiprolactinic veterinary
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0805544A
Other languages
English (en)
French (fr)
Other versions
FR2936710A1 (fr
Inventor
Anouck Lagarde
Stephane Floch
Thierry Bertaim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40527505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2936710(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Priority to FR0805544A priority Critical patent/FR2936710B1/fr
Priority to SI200931957T priority patent/SI2349272T1/sl
Priority to DK09783801.5T priority patent/DK2349272T3/da
Priority to AU2009301134A priority patent/AU2009301134B2/en
Priority to PT09783801T priority patent/PT2349272T/pt
Priority to UAA201105713A priority patent/UA103779C2/ru
Priority to PCT/EP2009/063004 priority patent/WO2010040765A1/fr
Priority to CA2738875A priority patent/CA2738875C/fr
Priority to NZ592288A priority patent/NZ592288A/xx
Priority to BRPI0914064A priority patent/BRPI0914064A2/pt
Priority to JP2011530475A priority patent/JP5955561B2/ja
Priority to KR1020117009774A priority patent/KR20110110091A/ko
Priority to EP09783801.5A priority patent/EP2349272B1/fr
Priority to KR1020177002975A priority patent/KR101892559B1/ko
Priority to PL09783801T priority patent/PL2349272T3/pl
Priority to RU2011118366/15A priority patent/RU2528892C2/ru
Priority to HK12102053.6A priority patent/HK1161555B/xx
Priority to MX2011003743A priority patent/MX2011003743A/es
Priority to HUE09783801A priority patent/HUE043239T2/hu
Priority to CN200980145820.7A priority patent/CN102215843B/zh
Priority to ES09783801T priority patent/ES2719844T3/es
Publication of FR2936710A1 publication Critical patent/FR2936710A1/fr
Publication of FR2936710B1 publication Critical patent/FR2936710B1/fr
Application granted granted Critical
Priority to IL212125A priority patent/IL212125B/en
Priority to US13/081,671 priority patent/US9730923B2/en
Priority to MA33803A priority patent/MA32763B1/fr
Priority to ZA2011/03273A priority patent/ZA201103273B/en
Priority to US13/828,023 priority patent/US9744158B2/en
Priority to NO2019028C priority patent/NO2019028I1/no
Priority to HUS1900036C priority patent/HUS1900036I1/hu
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR0805544A 2008-10-07 2008-10-07 Composition veterinaire antiprolactinique destinee aux ruminants Active FR2936710B1 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR0805544A FR2936710B1 (fr) 2008-10-07 2008-10-07 Composition veterinaire antiprolactinique destinee aux ruminants
PL09783801T PL2349272T3 (pl) 2008-10-07 2009-10-07 Przeciwprolaktynowa kompozycja weterynaryjna przeznaczona dla przeżuwaczy
RU2011118366/15A RU2528892C2 (ru) 2008-10-07 2009-10-07 Ветеринарная антипролактиновая композиция для жвачных
AU2009301134A AU2009301134B2 (en) 2008-10-07 2009-10-07 Antiprolactinic veterinary composition for ruminants
PT09783801T PT2349272T (pt) 2008-10-07 2009-10-07 Composição veterinária antiprolactínica para ruminantes
UAA201105713A UA103779C2 (ru) 2008-10-07 2009-10-07 Ветеринарная антипролактиновая композиция для жвачных
PCT/EP2009/063004 WO2010040765A1 (fr) 2008-10-07 2009-10-07 Composition veterinaire antiprolactinique destinee aux ruminants
CA2738875A CA2738875C (fr) 2008-10-07 2009-10-07 Composition veterinaire antiprolactinique destinee aux ruminants
NZ592288A NZ592288A (en) 2008-10-07 2009-10-07 Antiprolactinic veterinary composition for ruminants
MX2011003743A MX2011003743A (es) 2008-10-07 2009-10-07 Composicion antiprolactinica veterinaria para rumiantes.
JP2011530475A JP5955561B2 (ja) 2008-10-07 2009-10-07 反芻動物のための獣医用抗プロラクチン組成物
KR1020117009774A KR20110110091A (ko) 2008-10-07 2009-10-07 반추 동물용 항프롤락틴성 수의학적 조성물
EP09783801.5A EP2349272B1 (fr) 2008-10-07 2009-10-07 Composition veterinaire antiprolactinique destinee aux ruminants
KR1020177002975A KR101892559B1 (ko) 2008-10-07 2009-10-07 반추 동물용 항프롤락틴성 수의학적 조성물
SI200931957T SI2349272T1 (sl) 2008-10-07 2009-10-07 Antiprolaktinski veterinarski sestavek za prežvekovalce
HK12102053.6A HK1161555B (en) 2008-10-07 2009-10-07 Use of an antiprolactinic veterinary composition for the manufacture of a medicament
HUE09783801A HUE043239T2 (hu) 2008-10-07 2009-10-07 Állatgyógyászati antiprolaktin készítmény kérõdzõk számára
BRPI0914064A BRPI0914064A2 (pt) 2008-10-07 2009-10-07 composição veterinária, uso de composição veterinária e kit veterinário
DK09783801.5T DK2349272T3 (da) 2008-10-07 2009-10-07 Veterinær anti-prolaktin-sammensætning til drøvtyggere
CN200980145820.7A CN102215843B (zh) 2008-10-07 2009-10-07 抗催乳素兽医学组合物在制备药物中的用途
ES09783801T ES2719844T3 (es) 2008-10-07 2009-10-07 Composición veterinaria antiprolactínica para rumiantes
IL212125A IL212125B (en) 2008-10-07 2011-04-04 Veterinary compound of antiprolactin for ruminants
US13/081,671 US9730923B2 (en) 2008-10-07 2011-04-07 Antiprolactinic veterinary composition for ruminants
MA33803A MA32763B1 (fr) 2008-10-07 2011-05-02 Composition vétérinaire antiprolactinique destinés aux ruminants
ZA2011/03273A ZA201103273B (en) 2008-10-07 2011-05-05 Antiprolactinic veterinary composition for ruminants
US13/828,023 US9744158B2 (en) 2008-10-07 2013-03-14 Veterinary antiprolactinic composition for ruminants
NO2019028C NO2019028I1 (no) 2008-10-07 2019-07-05 Cabergoline
HUS1900036C HUS1900036I1 (hu) 2008-10-07 2019-07-08 Állatgyógyászati antiprolaktin készítmény kérõdzõk számára

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0805544A FR2936710B1 (fr) 2008-10-07 2008-10-07 Composition veterinaire antiprolactinique destinee aux ruminants

Publications (2)

Publication Number Publication Date
FR2936710A1 FR2936710A1 (fr) 2010-04-09
FR2936710B1 true FR2936710B1 (fr) 2011-01-07

Family

ID=40527505

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0805544A Active FR2936710B1 (fr) 2008-10-07 2008-10-07 Composition veterinaire antiprolactinique destinee aux ruminants

Country Status (24)

Country Link
US (2) US9730923B2 (https=)
EP (1) EP2349272B1 (https=)
JP (1) JP5955561B2 (https=)
KR (2) KR101892559B1 (https=)
CN (1) CN102215843B (https=)
AU (1) AU2009301134B2 (https=)
BR (1) BRPI0914064A2 (https=)
CA (1) CA2738875C (https=)
DK (1) DK2349272T3 (https=)
ES (1) ES2719844T3 (https=)
FR (1) FR2936710B1 (https=)
HU (2) HUE043239T2 (https=)
IL (1) IL212125B (https=)
MA (1) MA32763B1 (https=)
MX (1) MX2011003743A (https=)
NO (1) NO2019028I1 (https=)
NZ (1) NZ592288A (https=)
PL (1) PL2349272T3 (https=)
PT (1) PT2349272T (https=)
RU (1) RU2528892C2 (https=)
SI (1) SI2349272T1 (https=)
UA (1) UA103779C2 (https=)
WO (1) WO2010040765A1 (https=)
ZA (1) ZA201103273B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971423B1 (fr) 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
EP2995297A1 (fr) * 2014-09-09 2016-03-16 Ceva Sante Animale Compositions parentérales et leurs utilisations
US20200071408A1 (en) 2016-11-29 2020-03-05 National Center Of Neurology And Psychiatry Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
EP4064854A1 (en) 2019-11-28 2022-10-05 Boehringer Ingelheim Vetmedica GmbH Use of sglt-2 inhibitors in the drying-off of non-human mammals
UY39022A (es) * 2020-01-27 2021-07-30 Ceva Sante Animale Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria
AR122366A1 (es) * 2020-01-27 2022-09-07 Ceva Sante Animale Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839171A (en) * 1984-11-30 1989-06-13 Techmix, Inc. Composition for treating impaired lactation
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
NZ515178A (en) * 2001-11-23 2004-09-24 Agres Ltd Modulating prolactin receptors to affect a physiological response
GB0313892D0 (en) * 2003-06-16 2003-07-23 Hannah Res Inst Control of lactation
GB0314469D0 (en) 2003-06-20 2003-07-23 Phico Therapeutics Ltd Antimicrobial compositions and uses thereof
CN1762495B (zh) * 2004-09-21 2011-04-06 山东绿叶制药有限公司 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺
KR20070059161A (ko) * 2004-09-21 2007-06-11 산동 루예 파마슈티칼 컴파니 리미티드 도파민 수용체 효능제를 함유하는 장시간 작용 서방성 제제및 그 제조방법
EP1952813A1 (en) * 2007-02-01 2008-08-06 Ferring International Center S.A. Medicament for the treatment of endometriosis
ITTO20070479A1 (it) * 2007-07-02 2009-01-03 Ceva Vetem S P A Composizione veterinaria iniettabile ad attivita' anti-prolattinica

Also Published As

Publication number Publication date
KR20170017002A (ko) 2017-02-14
CN102215843A (zh) 2011-10-12
KR20110110091A (ko) 2011-10-06
US20110245261A1 (en) 2011-10-06
PT2349272T (pt) 2019-05-13
DK2349272T3 (da) 2019-04-29
SI2349272T1 (sl) 2019-07-31
MX2011003743A (es) 2011-07-28
RU2011118366A (ru) 2012-11-20
AU2009301134B2 (en) 2013-12-05
CA2738875C (fr) 2017-11-21
EP2349272A1 (fr) 2011-08-03
EP2349272B1 (fr) 2019-01-16
ES2719844T3 (es) 2019-07-16
HK1161555A1 (en) 2012-07-27
BRPI0914064A2 (pt) 2015-11-03
HUS1900036I1 (hu) 2019-07-29
RU2528892C2 (ru) 2014-09-20
IL212125B (en) 2020-06-30
US20130203762A1 (en) 2013-08-08
ZA201103273B (en) 2012-07-25
JP5955561B2 (ja) 2016-07-20
IL212125A0 (en) 2011-06-30
NO2019028I1 (no) 2019-07-05
FR2936710A1 (fr) 2010-04-09
MA32763B1 (fr) 2011-11-01
PL2349272T3 (pl) 2019-08-30
NZ592288A (en) 2013-03-28
HUE043239T2 (hu) 2019-08-28
AU2009301134A1 (en) 2010-04-15
CN102215843B (zh) 2014-07-30
US9744158B2 (en) 2017-08-29
KR101892559B1 (ko) 2018-08-28
WO2010040765A1 (fr) 2010-04-15
CA2738875A1 (fr) 2010-04-15
US9730923B2 (en) 2017-08-15
UA103779C2 (ru) 2013-11-25
JP2012505178A (ja) 2012-03-01

Similar Documents

Publication Publication Date Title
BRPI0906749A2 (pt) Composição
HRP20150477T1 (xx) Postupci dobivanja derivata kinazolona
BRPI0913808A2 (pt) composição
BRPI0913127A2 (pt) composição de resfriamento
BRPI0913569A2 (pt) anotação de imagens
EP2339264A4 (en) REFRIGERATION DEVICE
DK3421794T3 (da) Nedkølingsapparat
EP2374452A4 (en) NUTRIENT COMPOSITION
EP2246393A4 (en) HARDENING COMPOSITION
EP2264380A4 (en) REFRIGERATION DEVICE
BRPI0917231A2 (pt) composição
IT1392101B1 (it) Composizione comprendente isoflavoni
FR2936710B1 (fr) Composition veterinaire antiprolactinique destinee aux ruminants
BRPI0822882A2 (pt) Composição curável
DK2244628T3 (da) Patientdata-sensorapparat
EP2248835A4 (en) HARDENING COMPOSITION
FI20080493A0 (fi) Menetelmä hiilinielun mittaamiseksi
EP2280264A4 (en) STANDARD AGENTS
DK2995925T3 (da) Sammensætning til histokemisk processering
DK2240506T3 (da) IAP inhibitorer
EP2357204A4 (en) COMPOSITION
EP2383310A4 (en) HARDENING COMPOSITION
BRPI0917584A2 (pt) composição
IL195602A0 (en) An l-arginine-based formulation for oral absorption
DK2319515T3 (da) Coccidicid kombination til veterinær anvendelse

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18